MLICM
HLVX

Metropolitan Life Insurance Company (MetLife)’s HilleVax HLVX Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio HLVX Stock Details HLVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,561
Closed -$26K – 949
2024
Q1 		$26K Hold
1,561
– – ﹤0.01% 1733
2023
Q4 		$25.1K Buy
1,561
+363
+30% +$4.82K ﹤0.01% 1816
2023
Q3 		$16.1K Hold
1,198
– – ﹤0.01% 1994
2023
Q2 		$20.6K Buy
1,198
+287
+32% +$4.45K ﹤0.01% 1911
2023
Q1 		$15.1K Hold
911
– – ﹤0.01% 2011
2022
Q4 		$15.2K Hold
911
– – ﹤0.01% 2126
2022
Q3 		$15.6K Buy
+911
New +$13.2K ﹤0.01% 2140

Other funds holding HLVX

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CP
Catalys Pacific Tokyo, Japan $229M AUM 100.3% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s HLVX Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of HilleVax (HLVX) in Q2 2024, closing a stake of 1,561 shares — an estimated $26K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in HLVX in Q3 2022 and held it in 7 quarters. The position peaked at $26K in Q1 2024. 93 funds tracked by Wall St. Rank hold HLVX as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining HilleVax position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 1,561 HilleVax shares in Q2 2024, an estimated $26K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in HilleVax in Q3 2022 and held it in 7 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s HilleVax position peaked at $26K in Q1 2024.
  • 93 funds tracked by Wall St. Rank held HilleVax as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.